The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Cystine-knot cytokines
".
FunFam 4: Transforming growth factor beta
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 56 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
314 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(304 more) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
313 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(303 more) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
160 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
(150 more) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
98 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
F1NRQ9 (/ISS)
F1PR85 (/ISS)
F6Q651 (/ISS)
F6VL66 (/ISS)
F7DR45 (/ISS)
(88 more) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
98 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
F1NRQ9 (/ISS)
F1PR85 (/ISS)
F6Q651 (/ISS)
F6VL66 (/ISS)
F7DR45 (/ISS)
(88 more) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
31 |
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
B2R7T2 (/IMP)
P01137 (/IMP)
P01137 (/IMP)
(21 more) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
31 |
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
A5YM40 (/IMP)
B2R7T2 (/IMP)
P01137 (/IMP)
P01137 (/IMP)
(21 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
29 |
P01137 (/IPI)
P01137 (/IPI)
P04202 (/IPI)
P04202 (/IPI)
P07200 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
(19 more) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P61812 (/IDA)
(13 more) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
23 |
P01137 (/IPI)
P01137 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P10600 (/IPI)
P61812 (/IPI)
(13 more) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
16 |
P01137 (/TAS)
P01137 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(6 more) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
16 |
P01137 (/IPI)
P01137 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
P61812 (/IPI)
(6 more) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
16 |
P17246 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(6 more) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
14 |
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
(4 more) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
10 | P01137 (/IPI) P01137 (/IPI) P07200 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) P10600 (/IPI) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
5 | P04202 (/TAS) P04202 (/TAS) P17246 (/TAS) Q07257 (/TAS) Q07258 (/TAS) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
3 | P17246 (/IDA) Q07257 (/IDA) Q07258 (/IDA) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
2 | P04202 (/IPI) P04202 (/IPI) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Protein serine/threonine kinase activator activity GO:0043539
Binds to and increases the activity of a protein serine/threonine kinase.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
2 | P17246 (/IMP) Q07257 (/IMP) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
1 | P30371 (/ISA) |
Amyloid-beta binding GO:0001540
Interacting selectively and non-covalently with amyloid-beta peptide/protein and/or its precursor.
|
1 | P27090 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | P30371 (/ISA) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | P27090 (/ISO) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
1 | P30371 (/ISA) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
1 | P30371 (/ISA) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
1 | P27090 (/ISO) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
1 | P27090 (/TAS) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
1 | P30371 (/ISA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P30371 (/ISA) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
1 | P17125 (/ISO) |
There are 777 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
321 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(311 more) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
317 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(307 more) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
314 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(304 more) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
314 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(304 more) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
314 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(304 more) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
313 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(303 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
310 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(300 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
310 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(300 more) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
216 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(206 more) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
215 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(205 more) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
215 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(205 more) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
214 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(204 more) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
213 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(203 more) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
213 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(203 more) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
166 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(156 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
165 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(155 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
165 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
(155 more) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
165 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(155 more) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
160 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
(150 more) |
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
|
160 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
(150 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
158 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(148 more) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
158 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
(148 more) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
156 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(146 more) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of timing of catagen GO:0051795
Any process that activates or increases the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
154 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(144 more) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
153 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(143 more) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
153 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(143 more) |
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
|
153 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(143 more) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
145 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A8RRQ5 (/ISS)
(135 more) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
140 |
D2HL87 (/ISS)
D2HL87 (/ISS)
D2HL87 (/ISS)
F1PKH0 (/ISS)
F1PKH0 (/ISS)
F1PKH0 (/ISS)
F1PKH0 (/ISS)
F1PKH0 (/ISS)
F1PKH2 (/ISS)
F1PKH2 (/ISS)
(130 more) |
Signal transduction by protein phosphorylation GO:0023014
A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
|
135 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(125 more) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
117 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
F1NRQ9 (/ISS)
F1PR85 (/ISS)
F6Q651 (/ISS)
F6VL66 (/ISS)
F7DR45 (/ISS)
(107 more) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
98 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
F1NRQ9 (/ISS)
F1PR85 (/ISS)
F6Q651 (/ISS)
F6VL66 (/ISS)
F7DR45 (/ISS)
(88 more) |
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
98 |
A6QP91 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
D2GZY6 (/ISS)
F1NRQ9 (/ISS)
F1PR85 (/ISS)
F6Q651 (/ISS)
F6VL66 (/ISS)
F7DR45 (/ISS)
(88 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
69 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(59 more) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
69 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(59 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
65 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(55 more) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
63 |
D8V162 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
(53 more) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
61 |
D8V162 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
(51 more) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
60 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(50 more) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
60 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(50 more) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
60 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(50 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
60 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(50 more) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
60 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(50 more) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
58 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(48 more) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
50 |
D8V162 (/ISS)
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
(40 more) |
Hemopoiesis GO:0030097
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Neutrophil chemotaxis GO:0030593
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
|
32 |
P27090 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
32 |
P09858 (/ISS)
P27090 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Dopamine biosynthetic process GO:0042416
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Somatic stem cell division GO:0048103
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Neuron development GO:0048666
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Positive regulation of immune response GO:0050778
Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
32 |
P27090 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Hair follicle morphogenesis GO:0031069
The process in which the anatomical structures of the hair follicle are generated and organized.
|
31 |
P09858 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(21 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
25 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
(15 more) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
25 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
(15 more) |
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
|
23 |
P01137 (/TAS)
P01137 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P61812 (/TAS)
(13 more) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
23 |
P01137 (/IEP)
P01137 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P10600 (/IEP)
P61812 (/IEP)
(13 more) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P61812 (/IDA)
(13 more) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P61812 (/IDA)
(13 more) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P61812 (/IDA)
(13 more) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P61812 (/IDA)
(13 more) |
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
|
23 |
P10600 (/ISS)
P10600 (/ISS)
P10600 (/ISS)
P10600 (/ISS)
P10600 (/ISS)
P10600 (/ISS)
P10600 (/ISS)
P15203 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(13 more) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
21 |
P10600 (/NAS)
P10600 (/NAS)
P10600 (/NAS)
P10600 (/NAS)
P10600 (/NAS)
P10600 (/NAS)
P10600 (/NAS)
P61812 (/NAS)
P61812 (/NAS)
P61812 (/NAS)
(11 more) |
Uterine wall breakdown GO:0042704
The sloughing of the endometrium and blood vessels during menstruation that results from a drop in progesterone levels.
|
21 |
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(11 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
19 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(9 more) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
19 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P27090 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(9 more) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
18 |
P01137 (/IDA)
P01137 (/IDA)
P17125 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(8 more) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
18 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(8 more) |
Regulation of timing of catagen GO:0051794
Any process that modulates the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
18 |
P09858 (/ISS)
P27090 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(8 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
17 |
P01137 (/IDA)
P01137 (/IDA)
P17246 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(7 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
17 |
P04202 (/IDA)
P04202 (/IDA)
P17246 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(7 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
17 |
P01137 (/IDA)
P01137 (/IDA)
P27090 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(7 more) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
17 |
P01137 (/IDA)
P01137 (/IDA)
P17246 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(7 more) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
16 |
P01137 (/ISS)
P01137 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(6 more) |
Heart valve morphogenesis GO:0003179
The process in which the structure of a heart valve is generated and organized.
|
16 |
P01137 (/ISS)
P01137 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(6 more) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
16 |
P01137 (/IDA)
P01137 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(6 more) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
16 |
P01137 (/IEP)
P01137 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
(6 more) |
Positive regulation of microglia differentiation GO:0014008
Any process that activates, maintains or increases the frequency, rate or extent of microglia differentiation, the process in which a relatively unspecialized cell acquires specialized features of a microglial cell.
|
16 |
O19011 (/ISS)
O19011 (/ISS)
P01137 (/ISS)
P01137 (/ISS)
P07200 (/ISS)
P09531 (/ISS)
P09533 (/ISS)
P16176 (/ISS)
P16176 (/ISS)
P17246 (/ISS)
(6 more) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
16 |
P01137 (/IDA)
P01137 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(6 more) |
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
|
16 |
P16047 (/IEP)
P30371 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
(6 more) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
16 |
P01137 (/IMP)
P01137 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
(6 more) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
16 |
P01137 (/IDA)
P01137 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(6 more) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
16 |
P01137 (/IDA)
P01137 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(6 more) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
14 |
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
(4 more) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Pulmonary valve morphogenesis GO:0003184
The process in which the structure of the pulmonary valve is generated and organized.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Endocardial cushion morphogenesis GO:0003203
The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Ventricular trabecula myocardium morphogenesis GO:0003222
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Neural retina development GO:0003407
The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Embryo development ending in birth or egg hatching GO:0009792
The process whose specific outcome is the progression of an embryo over time, from zygote formation until the end of the embryonic life stage. The end of the embryonic life stage is organism-specific and may be somewhat arbitrary; for mammals it is usually considered to be birth, for insects the hatching of the first instar larva from the eggshell.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Neutrophil chemotaxis GO:0030593
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
14 |
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
P61812 (/IMP)
(4 more) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Ascending aorta morphogenesis GO:0035910
The process in which the anatomical structures of the ascending aorta are generated and organized. The ascending aorta is the portion of the aorta in a two-pass circulatory system that lies between the heart and the arch of aorta. In a two-pass circulatory system blood passes twice through the heart to supply the body once.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of Notch signaling pathway GO:0045747
Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
14 |
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
P61812 (/IEP)
(4 more) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Negative regulation of Ras protein signal transduction GO:0046580
Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Generation of neurons GO:0048699
The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
14 |
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
P61812 (/TAS)
(4 more) |
Regulation of timing of catagen GO:0051794
Any process that modulates the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of timing of catagen GO:0051795
Any process that activates or increases the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Regulation of apoptotic process involved in outflow tract morphogenesis GO:1902256
Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Substantia propria of cornea development GO:1903701
The process whose specific outcome is the progression of a substantia propria of cornea over time, from its formation to the mature structure.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Cranial skeletal system development GO:1904888
The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905006
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905007
Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
14 |
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
P61812 (/ISS)
(4 more) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
11 |
O19011 (/ISS)
O19011 (/ISS)
P01137 (/ISS)
P01137 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(1 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
11 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
(1 more) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
10 | P01137 (/IMP) P01137 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) Q07257 (/IMP) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
10 | P01137 (/IMP) P01137 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P17246 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
9 | P01137 (/IMP) P01137 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
9 | P01137 (/IEP) P01137 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) |
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
|
9 | P01137 (/IEP) P01137 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) P10600 (/IEP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
7 | P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) P10600 (/ISS) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
7 | P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) P10600 (/IMP) |
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Positive regulation of tight junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of tight junction disassembly.
|
7 | P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) P10600 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
6 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) P17125 (/IDA) P27090 (/IDA) |
Hematopoietic stem cell differentiation GO:0060218
The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
|
5 | E9QHW0 (/IGI) F1R741 (/IGI) Q66I23 (/IGI) Q7SZV3 (/IGI) Q7ZZU7 (/IGI) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
4 | P01137 (/IMP) P01137 (/IMP) P04202 (/IMP) P04202 (/IMP) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P01137 (/IMP) P01137 (/IMP) P04202 (/IMP) P04202 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Regulation of striated muscle tissue development GO:0016202
Any process that modulates the frequency, rate or extent of striated muscle development.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
4 | P17125 (/IMP) P17246 (/IMP) Q07257 (/IMP) Q07258 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Lymph node development GO:0048535
The process whose specific outcome is the progression of lymph nodes over time, from their formation to the mature structure. A lymph node is a round, oval, or bean shaped structure localized in clusters along the lymphatic vessels, with a distinct internal structure including specialized vasculature and B- and T-zones for the activation of lymphocytes.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Regulation of binding GO:0051098
Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Regulation of DNA binding GO:0051101
Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
4 | P04202 (/IEP) P04202 (/IEP) P17125 (/IEP) P27090 (/IEP) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
3 | P04202 (/IMP) P04202 (/IMP) P27090 (/IMP) |
Heart valve morphogenesis GO:0003179
The process in which the structure of a heart valve is generated and organized.
|
3 | P04202 (/IMP) P04202 (/IMP) P27090 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
3 | P04202 (/IMP) P04202 (/IMP) P27090 (/IMP) |
Skeletal muscle tissue development GO:0007519
The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
|
3 | P04202 (/TAS) P04202 (/TAS) P30371 (/TAS) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
3 | P01137 (/IDA) P01137 (/IDA) Q07257 (/IDA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
|
3 | P04202 (/IDA) P04202 (/IDA) P17125 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Response to laminar fluid shear stress GO:0034616
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
3 | P17246 (/TAS) P30371 (/TAS) Q07257 (/TAS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
3 | P04202 (/IGI) P04202 (/IGI) P17125 (/IGI) |
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Negative regulation of release of sequestered calcium ion into cytosol GO:0051280
Any process that stops, prevents, or reduces the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Frontal suture morphogenesis GO:0060364
The process in which the frontal suture is generated and organized.
|
3 | P17246 (/IEP) Q07257 (/IEP) Q07258 (/IEP) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
3 | P04202 (/IDA) P04202 (/IDA) P17125 (/IDA) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
3 | P01137 (/IDA) P01137 (/IDA) P27090 (/IDA) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
3 | P04202 (/ISO) P04202 (/ISO) P27090 (/ISO) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P04202 (/IGI) P04202 (/IGI) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P01137 (/IMP) P01137 (/IMP) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | P04202 (/TAS) P04202 (/TAS) |
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
|
2 | P17246 (/TAS) Q07257 (/TAS) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
2 | P04202 (/IEP) P04202 (/IEP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
2 | P17246 (/IEP) Q07258 (/IEP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
2 | P17125 (/ISO) P27090 (/ISO) |
Morphogenesis of a branching structure GO:0001763
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of sodium ion transport GO:0002028
Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Connective tissue replacement involved in inflammatory response wound healing GO:0002248
The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared that contribute to an inflammatory response.
|
2 | P01137 (/TAS) P01137 (/TAS) |
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment GO:0002362
The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO:0002460
An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Tolerance induction to self antigen GO:0002513
Tolerance induction directed at self antigens.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Epithelial to mesenchymal transition involved in endocardial cushion formation GO:0003198
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell that will contribute to the formation of the endocardial cushion.
|
2 | P16047 (/TAS) P30371 (/TAS) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
2 | P04202 (/ISO) P04202 (/ISO) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | P01137 (/IDA) P01137 (/IDA) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular calcium ion homeostasis GO:0006874
Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
2 | P01137 (/IDA) P01137 (/IDA) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Notch signaling pathway GO:0007219
A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
2 | P16047 (/TAS) P30371 (/TAS) |
Negative regulation of neuroblast proliferation GO:0007406
Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Skeletal muscle tissue development GO:0007519
The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
|
2 | P30371 (/IEP) Q07257 (/IEP) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Germ cell migration GO:0008354
The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
2 | P17246 (/IEP) Q07257 (/IEP) |
Defense response to fungus, incompatible interaction GO:0009817
A response of an organism to a fungus that prevents the occurrence or spread of disease.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of extracellular matrix disassembly GO:0010716
Any process that decreases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P01137 (/NAS) P01137 (/NAS) |
Macrophage derived foam cell differentiation GO:0010742
The process in which a monocyte acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Oligodendrocyte development GO:0014003
The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of microglia differentiation GO:0014008
Any process that activates, maintains or increases the frequency, rate or extent of microglia differentiation, the process in which a relatively unspecialized cell acquires specialized features of a microglial cell.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of striated muscle tissue development GO:0016202
Any process that modulates the frequency, rate or extent of striated muscle development.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of ossification GO:0030278
Any process that modulates the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | Q66I23 (/IMP) Q7SZV3 (/IMP) |
Negative regulation of ossification GO:0030279
Any process that stops, prevents, or reduces the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
2 | P17246 (/TAS) Q07257 (/TAS) |
Regulation of cell migration GO:0030334
Any process that modulates the frequency, rate or extent of cell migration.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of histone deacetylation GO:0031065
Any process that activates or increases the frequency, rate or extent of the removal of acetyl groups from histones.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of exit from mitosis GO:0031536
Any process that activates or increases the rate of progression from anaphase/telophase (high mitotic CDK activity) to G1 (low mitotic CDK activity).
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P17246 (/IEP) Q07257 (/IEP) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of interleukin-23 production GO:0032667
Any process that modulates the frequency, rate, or extent of interleukin-23 production.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of interleukin-17 production GO:0032700
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation GO:0032829
Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mononuclear cell proliferation GO:0032943
The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to vitamin D GO:0033280
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
|
2 | P17246 (/IEP) Q07257 (/IEP) |
Positive regulation of histone acetylation GO:0035066
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Posterior lateral line neuromast hair cell development GO:0035677
The process whose specific outcome is the progression of a posterior lateral line neuromast hair cell over time, from its formation to the mature structure. A neuromast hair cell is a hair cell that acts as a sensory receptor of the neuromast; it is morphologically polarized as a result of the relative position of the single kinocilium and the clusters of stereocilia on its apical surface. Cell development does not include the steps involved in committing a cell to a specific fate.
|
2 | F1R741 (/IMP) Q7ZZU7 (/IMP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
2 | O02730 (/IDA) Q6T7C3 (/IDA) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
2 | P17246 (/IMP) Q07257 (/IMP) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P04202 (/IDA) P04202 (/IDA) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of odontogenesis GO:0042482
Any process that activates or increases the frequency, rate or extent of the formation and development of a tooth or teeth.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
2 | P17246 (/IEP) Q07257 (/IEP) |
Myelination GO:0042552
The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Myeloid dendritic cell differentiation GO:0043011
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
|
2 | P04202 (/IMP) P04202 (/IMP) |
T cell homeostasis GO:0043029
The process of regulating the proliferation and elimination of T cells such that the total number of T cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P17246 (/IDA) Q07258 (/IDA) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
2 | Q07257 (/IDA) Q07258 (/IDA) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
2 | P17125 (/ISO) P27090 (/ISO) |
Regulatory T cell differentiation GO:0045066
The process in which a relatively unspecialized T cell acquires specialized features of a regulatory T cell. Regulatory T cells control or suppress immune responses through a variety of mechanisms and subsets include the CD4+CD25+ cell type as well as certain CD8+ cell types.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulatory T cell differentiation GO:0045066
The process in which a relatively unspecialized T cell acquires specialized features of a regulatory T cell. Regulatory T cells control or suppress immune responses through a variety of mechanisms and subsets include the CD4+CD25+ cell type as well as certain CD8+ cell types.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of regulatory T cell differentiation GO:0045589
Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of cell differentiation GO:0045596
Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P16047 (/IMP) P17125 (/IMP) |
Negative regulation of cytolysis GO:0045918
Any process that stops, prevents, or reduces the frequency, rate or extent of cytolysis.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cytolysis GO:0045918
Any process that stops, prevents, or reduces the frequency, rate or extent of cytolysis.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Muscle cell cellular homeostasis GO:0046716
The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lymph node development GO:0048535
The process whose specific outcome is the progression of lymph nodes over time, from their formation to the mature structure. A lymph node is a round, oval, or bean shaped structure localized in clusters along the lymphatic vessels, with a distinct internal structure including specialized vasculature and B- and T-zones for the activation of lymphocytes.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Spleen development GO:0048536
The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions.
|
2 | P16047 (/IEP) P30371 (/IEP) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
|
2 | Q07257 (/IDA) Q07258 (/IDA) |
Embryonic neurocranium morphogenesis GO:0048702
The process in which the anatomical structures of the neurocranium are generated and organized during the embryonic phase. The neurocranium is the portion of the vertebrate skull surrounding the brain.
|
2 | P17125 (/ISO) P27090 (/ISO) |
Otolith development GO:0048840
The process whose specific outcome is the progression of the otolith over time, from its formation to the mature structure.
|
2 | F1R741 (/IMP) Q7ZZU7 (/IMP) |
Posterior lateral line neuromast development GO:0048919
The process whose specific outcome is the progression of the posterior lateral line neuromast over time, from its formation to the mature structure. The neuromast is the sensory receptor of the anterior lateral line system and is composed of a population of sensory hair cells, and nonsensory supporting cells and mantle cells. Neuromast are located superficially on the epithelium or in lateral line canals.
|
2 | F1R741 (/IMP) Q7ZZU7 (/IMP) |
Posterior lateral line neuromast primordium migration GO:0048920
The migration of a relatively undifferentiated cell along the developing posterior lateral line, originating from cranial ectodermal placodes situated behind the ear. The neuromast primordium deposits proneuromasts along the lateral line, from which the neuromasts will develop.
|
2 | F1R741 (/IMP) Q7ZZU7 (/IMP) |
Posterior lateral line neuromast deposition GO:0048922
The process in which a migrating neuromast primordium deposits clusters of undifferentiated cells (proneuromasts) along its migratory path in the developing posterior lateral line.
|
2 | F1R741 (/IMP) Q7ZZU7 (/IMP) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
2 | P17246 (/IDA) Q07257 (/IDA) |
Negative regulation of T cell activation GO:0050868
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of binding GO:0051098
Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulation of DNA binding GO:0051101
Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of smooth muscle cell differentiation GO:0051152
Any process that activates or increases the frequency, rate or extent of smooth muscle cell differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of release of sequestered calcium ion into cytosol GO:0051280
Any process that stops, prevents, or reduces the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
2 | P17246 (/IDA) Q07257 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Ventricular cardiac muscle tissue morphogenesis GO:0055010
The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Ventricular cardiac muscle tissue morphogenesis GO:0055010
The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Hard palate development GO:0060022
The biological process whose specific outcome is the progression of the hard palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. The hard palate is the anterior portion of the palate consisting of bone and mucous membranes.
|
2 | F8W4A6 (/IMP) Q7SZV4 (/IMP) |
Regulation of blood vessel remodeling GO:0060312
Any process that modulates the rate, frequency or extent of blood vessel remodeling, the reorganization or renovation of existing blood vessels.
|
2 | P01137 (/IC) P01137 (/IC) |
Regulation of blood vessel remodeling GO:0060312
Any process that modulates the rate, frequency or extent of blood vessel remodeling, the reorganization or renovation of existing blood vessels.
|
2 | P01137 (/NAS) P01137 (/NAS) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P16047 (/TAS) P30371 (/TAS) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mammary gland branching involved in thelarche GO:0060744
The process in which the branching structure of the mammary gland duct is generated and organized during the period of sexual maturity in mammals. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Branch elongation involved in mammary gland duct branching GO:0060751
The developmental growth process in which a branch of a mammary gland duct elongates.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of branching involved in mammary gland duct morphogenesis GO:0060762
Any process that modulates the rate, frequency, or extent of branching involved in mammary gland duct morphogenesis.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of cartilage development GO:0061035
Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulation of cartilage development GO:0061035
Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | Q66I23 (/IMP) Q7SZV3 (/IMP) |
Sclerotome development GO:0061056
The progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra.
|
2 | F8W4A6 (/IMP) Q7SZV4 (/IMP) |
Connective tissue development GO:0061448
The progression of a connective tissue over time, from its formation to the mature structure.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Secondary palate development GO:0062009
The biological process whose specific outcome is the progression of the secondary palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The secondary palate is the part of the palate formed from the fusion of the two palatine shelves, extensions of the maxillary prominences.
|
2 | P17125 (/IMP) P27090 (/IMP) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lens fiber cell differentiation GO:0070306
The process in which a relatively unspecialized cell acquires specialized features of a lens fiber cell, any of the elongated, tightly packed cells that make up the bulk of the mature lens in the camera-type eye. The cytoplasm of a lens fiber cell is devoid of most intracellular organelles including the cell nucleus, and contains primarily crystallins, a group of water-soluble proteins expressed in vary large quantities.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cell cycle arrest GO:0071158
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of mononuclear cell migration GO:0071677
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
2 | P04202 (/ISO) P04202 (/ISO) |
T-helper 17 cell lineage commitment GO:0072540
The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of extracellular matrix assembly GO:1901203
Any process that activates or increases the frequency, rate or extent of extracellular matrix assembly.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799
Any process that stops, prevents or reduces the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799
Any process that stops, prevents or reduces the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of receptor clustering GO:1903911
Any process that activates or increases the frequency, rate or extent of receptor clustering.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Transforming growth factor beta receptor signaling pathway involved in heart development GO:1905313
Any transforming growth factor beta receptor signaling pathway that is involved in heart development.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Transforming growth factor beta receptor signaling pathway involved in heart development GO:1905313
Any transforming growth factor beta receptor signaling pathway that is involved in heart development.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Embryonic liver development GO:1990402
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Embryonic liver development GO:1990402
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Regulation of actin cytoskeleton reorganization GO:2000249
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cardiac muscle cell differentiation GO:2000727
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of cardiac muscle cell differentiation GO:2000727
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
1 | Q07258 (/IDA) |
Activation of MAPK activity GO:0000187
The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
|
1 | P17125 (/ISO) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
1 | P30371 (/ISA) |
Cell morphogenesis GO:0000902
The developmental process in which the size or shape of a cell is generated and organized.
|
1 | P27090 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | P27090 (/IMP) |
Cartilage condensation GO:0001502
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
|
1 | P27090 (/IGI) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
1 | P27090 (/IMP) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
1 | P30371 (/IEP) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
1 | P30371 (/ISA) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
1 | P27090 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P30371 (/ISA) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
1 | P17125 (/IMP) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
1 | P09858 (/TAS) |
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
1 | P30371 (/IEP) |
Morphogenesis of a branching structure GO:0001763
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
|
1 | P17246 (/IDA) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | P16047 (/TAS) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | Q07257 (/IEP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P27090 (/IMP) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P30371 (/ISA) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
1 | P27090 (/IMP) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
1 | P27090 (/ISO) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
1 | P27090 (/IMP) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P30371 (/ISA) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P27090 (/ISO) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
1 | P27090 (/IMP) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
1 | P27090 (/IMP) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
1 | P27090 (/TAS) |
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
|
1 | P27090 (/IMP) |
Pulmonary valve morphogenesis GO:0003184
The process in which the structure of the pulmonary valve is generated and organized.
|
1 | P27090 (/IMP) |
Endocardial cushion morphogenesis GO:0003203
The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
1 | P27090 (/IMP) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
1 | P27090 (/TAS) |
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
|
1 | P27090 (/IMP) |
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
|
1 | P27090 (/TAS) |
Ventricular trabecula myocardium morphogenesis GO:0003222
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized.
|
1 | P27090 (/IMP) |
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
|
1 | P27090 (/IMP) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
1 | P27090 (/IMP) |
Neural retina development GO:0003407
The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells.
|
1 | P27090 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
1 | P30371 (/ISA) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
1 | P30371 (/ISA) |
Negative regulation of cell adhesion GO:0007162
Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
|
1 | P30371 (/TAS) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P30371 (/ISA) |
Negative regulation of neuroblast proliferation GO:0007406
Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
|
1 | P17246 (/IDA) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
1 | P27090 (/IMP) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
1 | P30371 (/ISA) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P30371 (/IEP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P30371 (/ISA) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P27090 (/ISO) |
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
|
1 | P30371 (/ISA) |
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
|
1 | P27090 (/ISO) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | P30371 (/ISA) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P30371 (/ISA) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
1 | P30371 (/ISA) |
Glial cell migration GO:0008347
The orderly movement of a glial cell, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.
|
1 | P27090 (/ISO) |
Gonad development GO:0008406
The process whose specific outcome is the progression of the gonad over time, from its formation to the mature structure. The gonad is an animal organ that produces gametes; in some species it also produces hormones.
|
1 | P30371 (/TAS) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | P30371 (/IEP) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | P27090 (/IMP) |
Female gonad development GO:0008585
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure.
|
1 | P30371 (/IEP) |
Response to cold GO:0009409
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.
|
1 | Q07257 (/IEP) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
1 | P30371 (/ISA) |
Response to virus GO:0009615
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
|
1 | P30371 (/IDA) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P17246 (/IEP) |
Embryo development ending in birth or egg hatching GO:0009792
The process whose specific outcome is the progression of an embryo over time, from zygote formation until the end of the embryonic life stage. The end of the embryonic life stage is organism-specific and may be somewhat arbitrary; for mammals it is usually considered to be birth, for insects the hatching of the first instar larva from the eggshell.
|
1 | P30371 (/IEP) |
Defense response to fungus, incompatible interaction GO:0009817
A response of an organism to a fungus that prevents the occurrence or spread of disease.
|
1 | P17246 (/IDA) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | P17125 (/IMP) |
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
1 | P30371 (/ISA) |
Cardioblast differentiation GO:0010002
The process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
1 | P27090 (/ISO) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P17246 (/IDA) |
Response to organonitrogen compound GO:0010243
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond.
|
1 | Q07257 (/IEP) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
1 | P30371 (/ISA) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
1 | P27090 (/ISO) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
1 | P30371 (/ISA) |
Negative regulation of alkaline phosphatase activity GO:0010693
Any process that decreases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
1 | P27090 (/ISO) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P17125 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P30371 (/ISA) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P17125 (/IMP) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | P30371 (/ISA) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
1 | P30371 (/ISA) |
Positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
|
1 | P27090 (/ISO) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | P17246 (/IEP) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
1 | P30371 (/ISA) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
1 | P27090 (/ISO) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
1 | P30371 (/IEP) |
Signal transduction by protein phosphorylation GO:0023014
A process in which the transfer of one or more phosphate groups to a substrate transmits a signal to the phosphorylated substrate.
|
1 | P30371 (/ISA) |
Hemopoiesis GO:0030097
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
|
1 | P27090 (/IMP) |
Extracellular matrix organization GO:0030198
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
|
1 | P27090 (/IMP) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
1 | P30371 (/ISA) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
1 | P27090 (/ISO) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P30371 (/ISA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P27090 (/ISO) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
1 | P30371 (/ISA) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | P30371 (/IEP) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | Q07258 (/NAS) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
1 | P27090 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | P16047 (/TAS) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
1 | Q07258 (/IDA) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
1 | P17125 (/ISO) |
Neutrophil chemotaxis GO:0030593
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
|
1 | P09858 (/IDA) |
Regulation of epithelial cell differentiation GO:0030856
Any process that modulates the frequency, rate or extent of epithelial cell differentiation.
|
1 | Q07258 (/TAS) |
Thyroid gland development GO:0030878
The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
|
1 | Q07257 (/IEP) |
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
|
1 | Q07257 (/IEP) |
Pancreas development GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
|
1 | Q07257 (/IEP) |
Hair follicle morphogenesis GO:0031069
The process in which the anatomical structures of the hair follicle are generated and organized.
|
1 | P27090 (/IMP) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
1 | P17246 (/IMP) |
Positive regulation of exit from mitosis GO:0031536
Any process that activates or increases the rate of progression from anaphase/telophase (high mitotic CDK activity) to G1 (low mitotic CDK activity).
|
1 | P17246 (/IDA) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
1 | P30371 (/ISA) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
1 | P27090 (/ISO) |
Response to retinoic acid GO:0032526
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.
|
1 | Q07257 (/IEP) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
1 | P30371 (/ISA) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
1 | P30371 (/ISA) |
Positive regulation of stress-activated MAPK cascade GO:0032874
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
1 | P27090 (/ISO) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
1 | P30371 (/ISA) |
Regulation of transforming growth factor beta2 production GO:0032909
Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
|
1 | P27090 (/ISO) |
Regulation of actin cytoskeleton organization GO:0032956
Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
|
1 | P27090 (/IDA) |
Positive regulation of mammary gland epithelial cell proliferation GO:0033601
Any process that activates or increases the rate or extent of mammary gland epithelial cell proliferation.
|
1 | P18341 (/IMP) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
1 | P30371 (/ISA) |
Positive regulation of cell adhesion mediated by integrin GO:0033630
Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.
|
1 | P27090 (/ISO) |
Positive regulation of luteinizing hormone secretion GO:0033686
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.
|
1 | P09531 (/IEP) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
1 | Q07257 (/IEP) |
Response to immobilization stress GO:0035902
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of being rendered immobile.
|
1 | P17246 (/IEP) |
Ascending aorta morphogenesis GO:0035910
The process in which the anatomical structures of the ascending aorta are generated and organized. The ascending aorta is the portion of the aorta in a two-pass circulatory system that lies between the heart and the arch of aorta. In a two-pass circulatory system blood passes twice through the heart to supply the body once.
|
1 | P27090 (/IMP) |
Regulation of growth GO:0040008
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
|
1 | P30371 (/NAS) |
Endothelial cell activation GO:0042118
The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | P30371 (/NAS) |
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
|
1 | P09531 (/IEP) |
Dopamine biosynthetic process GO:0042416
The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
|
1 | P27090 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P30371 (/ISA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P27090 (/ISO) |
Myelination GO:0042552
The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
|
1 | P17246 (/IMP) |
Progesterone secretion GO:0042701
The regulated release of progesterone, a steroid hormone, by the corpus luteum of the ovary and by the placenta.
|
1 | P09531 (/IEP) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
1 | P27090 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q07257 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | P27090 (/ISO) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
1 | P17125 (/IMP) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
1 | P30371 (/ISA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
1 | P27090 (/ISO) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
1 | P30371 (/ISA) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
1 | P30371 (/NAS) |
Regulation of endothelial cell differentiation GO:0045601
Any process that modulates the frequency, rate or extent of endothelial cell differentiation.
|
1 | Q07258 (/TAS) |
Negative regulation of keratinocyte differentiation GO:0045617
Any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte differentiation.
|
1 | P27090 (/NAS) |
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
|
1 | P30371 (/ISA) |
Positive regulation of integrin biosynthetic process GO:0045726
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.
|
1 | P27090 (/ISO) |
Positive regulation of Notch signaling pathway GO:0045747
Any process that activates or increases the frequency, rate or extent of the Notch signaling pathway.
|
1 | P27090 (/ISO) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
1 | P30371 (/ISA) |
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
|
1 | P27090 (/IMP) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
1 | P30371 (/ISA) |
Positive regulation of heart contraction GO:0045823
Any process that activates or increases the frequency, rate or extent of heart contraction.
|
1 | P27090 (/ISO) |
Negative regulation of Ras protein signal transduction GO:0046580
Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction.
|
1 | P27090 (/IMP) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P09531 (/IEP) |
Somatic stem cell division GO:0048103
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
|
1 | P27090 (/IDA) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | P18341 (/IMP) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
1 | P17125 (/IMP) |
Animal organ development GO:0048513
Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | P30371 (/TAS) |
Embryonic digestive tract development GO:0048566
The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.
|
1 | P30371 (/ISA) |
Embryonic organ development GO:0048568
Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | P30371 (/IEP) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
1 | P27090 (/IDA) |
Neuron development GO:0048666
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
1 | P27090 (/IMP) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
1 | P27090 (/IMP) |
Regulation of epithelial cell proliferation GO:0050678
Any process that modulates the frequency, rate or extent of epithelial cell proliferation.
|
1 | Q07258 (/TAS) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
1 | P17246 (/IDA) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
1 | P30371 (/ISA) |
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
|
1 | P09531 (/IEP) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
1 | P30371 (/ISA) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
1 | P17246 (/IDA) |
Positive regulation of immune response GO:0050778
Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
1 | P09858 (/IDA) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
1 | P17246 (/IDA) |
Positive regulation of smooth muscle cell differentiation GO:0051152
Any process that activates or increases the frequency, rate or extent of smooth muscle cell differentiation.
|
1 | P17246 (/IDA) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
1 | P30371 (/TAS) |
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
1 | P17125 (/IMP) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
1 | P17125 (/ISO) |
Regulation of timing of catagen GO:0051794
Any process that modulates the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
1 | P27090 (/ISO) |
Positive regulation of timing of catagen GO:0051795
Any process that activates or increases the frequency, rate or extent of timing of catagen, the regression phase of the hair cycle.
|
1 | P27090 (/ISO) |
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
1 | P30371 (/ISA) |
Positive regulation of cardioblast differentiation GO:0051891
Any process that activates or increases the frequency, rate or extent of cardioblast differentiation, the process in which a relatively unspecialized mesodermal cell acquires the specialized structural and/or functional features of a cardioblast. A cardioblast is a cardiac precursor cell. It is a cell that has been committed to a cardiac fate, but will undergo more cell division rather than terminally differentiating.
|
1 | P27090 (/ISO) |
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
|
1 | P30371 (/ISA) |
Cardiac muscle cell proliferation GO:0060038
The expansion of a cardiac muscle cell population by cell division.
|
1 | P27090 (/ISO) |
Uterus development GO:0060065
The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
|
1 | P27090 (/IMP) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P16047 (/IMP) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P30371 (/ISA) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P27090 (/ISO) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
1 | P17125 (/ISO) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
1 | P30371 (/ISA) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P30371 (/ISA) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | P17125 (/IMP) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
1 | P27090 (/ISO) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
1 | P27090 (/IMP) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
1 | P27090 (/TAS) |
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
|
1 | P27090 (/IMP) |
Response to growth hormone GO:0060416
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
1 | P30371 (/IEP) |
Negative regulation of cartilage development GO:0061037
Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
1 | P27090 (/IMP) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
1 | P27090 (/IMP) |
Positive regulation of activation-induced cell death of T cells GO:0070237
Any process that activates or increases the frequency, rate or extent of activation-induced cell death of T cells.
|
1 | P27090 (/IDA) |
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P17125 (/ISO) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P17246 (/IEP) |
Cellular response to ionizing radiation GO:0071479
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
|
1 | P17246 (/IEP) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
1 | P17246 (/IDA) |
Positive regulation of mononuclear cell migration GO:0071677
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
1 | P17246 (/IMP) |
Positive regulation of extracellular matrix disassembly GO:0090091
Any process that increases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
|
1 | P27090 (/IDA) |
Mesenchyme migration GO:0090131
The process in which the population of cells that make up a mesenchyme undergo directed movement.
|
1 | P16047 (/IMP) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
1 | P17246 (/IMP) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
1 | P30371 (/ISA) |
Liver regeneration GO:0097421
The regrowth of lost or destroyed liver.
|
1 | P17246 (/IEP) |
Response to salt GO:1902074
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus.
|
1 | P17246 (/IEP) |
Regulation of apoptotic process involved in outflow tract morphogenesis GO:1902256
Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis.
|
1 | P27090 (/IMP) |
Regulation of extracellular matrix organization GO:1903053
Any process that modulates the frequency, rate or extent of extracellular matrix organization.
|
1 | P27090 (/IMP) |
Positive regulation of transdifferentiation GO:1903620
Any process that activates or increases the frequency, rate or extent of transdifferentiation.
|
1 | P18341 (/IMP) |
Regulation of complement-dependent cytotoxicity GO:1903659
Any process that modulates the frequency, rate or extent of complement-dependent cytotoxicity.
|
1 | P30371 (/ISA) |
Substantia propria of cornea development GO:1903701
The process whose specific outcome is the progression of a substantia propria of cornea over time, from its formation to the mature structure.
|
1 | P27090 (/IMP) |
Positive regulation of GTP binding GO:1904426
Any process that activates or increases the frequency, rate or extent of GTP binding.
|
1 | P27090 (/IDA) |
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
1 | P17125 (/ISO) |
Cranial skeletal system development GO:1904888
The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus.
|
1 | P27090 (/IMP) |
Negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905006
Any process that stops, prevents or reduces the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
1 | P27090 (/IMP) |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905007
Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
1 | P27090 (/IMP) |
Positive regulation of tight junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of tight junction disassembly.
|
1 | P17125 (/ISO) |
Cellular response to insulin-like growth factor stimulus GO:1990314
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
1 | P17246 (/IEP) |
Positive regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001241
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
|
1 | P27090 (/IDA) |
There are 49 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
251 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(241 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
206 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(196 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
151 |
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087QXC5 (/ISS)
A0A087V5Z8 (/ISS)
(141 more) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(52 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F1PMQ2 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
(51 more) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
32 |
P09858 (/ISS)
P30371 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
P61811 (/ISS)
(22 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
24 |
P01137 (/TAS)
P01137 (/TAS)
P09533 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
(14 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
23 |
P01137 (/IDA)
P01137 (/IDA)
P04202 (/IDA)
P04202 (/IDA)
P17246 (/IDA)
P27090 (/IDA)
P30371 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(13 more) |
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
|
23 |
P01137 (/TAS)
P01137 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P10600 (/TAS)
P61812 (/TAS)
(13 more) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
22 |
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P17246 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(12 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
14 |
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
P61812 (/IDA)
(4 more) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
14 |
A5YM40 (/IDA)
A5YM40 (/IDA)
A5YM40 (/IDA)
A5YM40 (/IDA)
A5YM40 (/IDA)
A5YM40 (/IDA)
A5YM40 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
P10600 (/IDA)
(4 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) P10600 (/IC) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
5 | P01137 (/IDA) P01137 (/IDA) P17246 (/IDA) Q07257 (/IDA) Q07258 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
4 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) P27090 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
3 | P01137 (/IDA) P01137 (/IDA) Q07258 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
3 | P17246 (/IDA) Q07257 (/IDA) Q07258 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
3 | P17246 (/IDA) Q07257 (/IDA) Q07258 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
3 | P04202 (/IDA) P04202 (/IDA) P17125 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
3 | P17246 (/IDA) P27090 (/IDA) Q07258 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
3 | P04202 (/ISO) P04202 (/ISO) P17125 (/ISO) |
Golgi lumen GO:0005796
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
2 | P17246 (/IDA) P27090 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P01137 (/HDA) P01137 (/HDA) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
2 | P01137 (/HDA) P01137 (/HDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | P30371 (/ISA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
1 | P27090 (/ISO) |
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
|
1 | Q07257 (/IDA) |
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
|
1 | P27090 (/ISO) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P27090 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P30371 (/ISA) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
1 | P27090 (/IDA) |
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
|
1 | Q07257 (/IDA) |
Trans-Golgi network GO:0005802
The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination.
|
1 | P27090 (/ISO) |
T-tubule GO:0030315
Invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril. The ends of T-tubules make contact with the sarcoplasmic reticulum membrane.
|
1 | Q07258 (/IDA) |
T-tubule GO:0030315
Invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril. The ends of T-tubules make contact with the sarcoplasmic reticulum membrane.
|
1 | P17125 (/ISO) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
1 | P30371 (/ISA) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
1 | P17125 (/ISO) |